These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18040790)

  • 1. Neuroimmunity, drugs of abuse, and neuroAIDS.
    Burdo TH; Katner SN; Taffe MA; Fox HS
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):41-9. PubMed ID: 18040790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.
    Buckner CM; Luers AJ; Calderon TM; Eugenin EA; Berman JW
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):160-81. PubMed ID: 18040782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.
    Bell JE; Arango JC; Anthony IC
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):182-91. PubMed ID: 18040783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.
    Hauser KF; El-Hage N; Stiene-Martin A; Maragos WF; Nath A; Persidsky Y; Volsky DJ; Knapp PE
    J Neurochem; 2007 Feb; 100(3):567-86. PubMed ID: 17173547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse.
    Sagar V; Atluri VS; Pilakka-Kanthikeel S; Nair M
    Mol Brain; 2016 May; 9(1):57. PubMed ID: 27216740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of HIV-associated disease of the central nervous system.
    Mallard J; Williams KC
    Handb Clin Neurol; 2018; 152():41-53. PubMed ID: 29604983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 neuroimmunity in the era of antiretroviral therapy.
    Kraft-Terry SD; Stothert AR; Buch S; Gendelman HE
    Neurobiol Dis; 2010 Mar; 37(3):542-8. PubMed ID: 20044002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.
    Kaul M; Lipton SA
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):138-51. PubMed ID: 18040780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.
    Kraft-Terry SD; Buch SJ; Fox HS; Gendelman HE
    Neuron; 2009 Oct; 64(1):133-45. PubMed ID: 19840555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.
    Berman JW; Carson MJ; Chang L; Cox BM; Fox HS; Gonzalez RG; Hanson GR; Hauser KF; Ho WZ; Hong JS; Major EO; Maragos WF; Masliah E; McArthur JC; Miller DB; Nath A; O'Callaghan JP; Persidsky Y; Power C; Rogers TJ; Royal W
    J Neuroimmune Pharmacol; 2006 Dec; 1(4):351-99. PubMed ID: 18040811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis.
    Goodkin K; Shapshak P; Metsch LR; McCoy CB; Crandall KA; Kumar M; Fujimura RK; McCoy V; Zhang BT; Reyblat S; Xin KQ; Kumar AM
    J Neuroimmunol; 1998 Mar; 83(1-2):88-101. PubMed ID: 9610677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
    Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
    Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for interactions of HIV and drugs of abuse.
    Nath A; Hauser KF; Wojna V; Booze RM; Maragos W; Prendergast M; Cass W; Turchan JT
    J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S62-9. PubMed ID: 12394784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs of abuse, immune modulation, and AIDS.
    Cabral GA
    J Neuroimmune Pharmacol; 2006 Sep; 1(3):280-95. PubMed ID: 18040805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathogenesis of human immunodeficiency virus infection.
    Sillman B; Woldstad C; Mcmillan J; Gendelman HE
    Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
    Lindl KA; Marks DR; Kolson DL; Jordan-Sciutto KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):294-309. PubMed ID: 20396973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feline model of neuroAIDS: understanding the progression towards AIDS dementia.
    Podell M; March PA; Buck WR; Mathes LE
    J Psychopharmacol; 2000; 14(3):205-13. PubMed ID: 11106298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Neuropathology of HIV/AIDS.
    Anthony IC; Bell JE
    Int Rev Psychiatry; 2008 Feb; 20(1):15-24. PubMed ID: 18240059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling neuroHIV in the Presence of Substance Use Disorders.
    Lin Y; He JJ; Sorensen R; Chang L
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):578-583. PubMed ID: 33215327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report.
    Kopnisky KL; Bao J; Lin YW
    Brain Behav Immun; 2007 May; 21(4):428-41. PubMed ID: 17346925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.